General Information
Version
6.4
Revision date
2025-10-07
Product name
Thidiazuron
CAS No.
51707-55-2
REACH No
A
Emergency telephone
+44 (0)870 8200418
Icons in SDS
Company Information
company name
Merck Life Science UK Limited
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H319, H335, H410
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Skin irritation, (Category 2) H315: Causes skin irritation. Eye irritation, (Category 2) H319: Causes serious eye irritation. Specific target organ toxicity - H335: May cause respiratory irritation. single exposure, (Category 3), Respiratory system Short-term (acute) aquatic H400: Very toxic to aquatic life. hazard, (Category 1) Long-term (chronic) aquatic H410: Very toxic to aquatic life with long hazard, (Category 1) lasting effects.
Signal word
Warning Warning
Hazard statements
H315 Causes skin irritation. H319 Causes serious eye irritation. H335 May cause respiratory irritation. H410 Very toxic to aquatic life with long lasting effects. none
Precautionary statements
P261 Avoid breathing dust. P264 Wash skin thoroughly after handling. P271 Use only outdoors or in a well-ventilated area. P273 Avoid release to the environment. P302 + P352 IF ON SKIN: Wash with plenty of water. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. none
Supplemental label elements
none Reduced Labelling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
